284.73
284.73 (0%)
As of Apr 17, 2025
UNITED THERAPEUTICS Corp [UTHR]
Source:
Company Overview
United Therapeutics Corp is the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation (PBC). Our public benefit purpose is to provide a brighter future for patients through (a) the development of novel pharmaceutical therapies; and (b) technologies that expand the availability of transplantable organs.
| Country | United States |
| Headquarters | silver spring, maryland |
| Phone Number | 3016089292 |
| Industry | manufacturing |
| CEO | Martine Rothblatt |
| Website | https://www.unither.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $2,877.4 |
| Operating Profit | $1,377 |
| Net Income | $1,195.1 |
| Net Cash | $489,500,000 |
Profit Ratios
| Gross Margin | $2,567.7 |
| Operating Margin | 47.9 |
| Profit as % of Revenues | 214.9% |
| Profit as % of Assets | 16.5% |
| Profit as % of Stockholder Equity | 18.6% |
Management Effectiveness
| Return on Equity | 18.6% |
| Return on Assets | 16.2% |
| Turnover Ratio | 39.6% |
| EBITA | $1,377 |
Balance Sheet and Cash Flow Measures
| Total Assets | $7,364 |
| Total Liabilities | $920 |
| Operating Cash Flow | $1,327,100,000 |
| Investing Cash Flow | $417,200,000 |
| Financing Cash Flow | $-1,254,800,000 |
